Literature DB >> 16918715

The molecular mechanism of resistance to methotrexate in mouse methotrexate-resistant cells by cancer drug resistance and metabolism SuperArray.

Chun-yu Zhang1, Yuan-xi Feng, Yang Yu, Wen-jing Sun, Jing Bai, Feng Chen, Song-bin Fu.   

Abstract

Drug resistance is often a limiting factor in successful chemotherapy. Understanding of the molecular mechanism of resistance to methotrexate is important for optimal use as well as for the development of new drugs. Using standard cytogenetic techniques, double minutes (DMs) were detected in mouse methotrexate-resistant cell lines inducted in vitro in this study. Moreover, functional SuperArray, determining the regulation of gene expression corresponding to 96 genes involved in the metabolism of and the development of resistance to cancer drugs was used to study in detail the molecular mechanism of resistance to methotrexate. Significant higher expressions of many genes especially dhfr, mrp5, atm and p53 were detected in methotrexate-resistant cells than in normal mouse cells by SuperArray analysis and corresponding excessive expressions of DHFR, MRP5, ATM, and P53 proteins in methotrexate-resistant cells were also confirmed by Western blot analysis. The results in this study indicated that DHFR, MRP5, ATM, and P53 could play important roles in resistance to methotrexate and some of them would be new potential drug targets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16918715     DOI: 10.1111/j.1742-7843.2006.pto_470.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  9 in total

Review 1.  Revisiting characteristics of oncogenic extrachromosomal DNA as mobile enhancers on neuroblastoma and glioma cancers.

Authors:  Mohsen Karami Fath; Nastaran Karimfar; Andarz Fazlollahpour Naghibi; Shahriyar Shafa; Melika Ghasemi Shiran; Mehran Ataei; Hossein Dehghanzadeh; Mohsen Nabi Afjadi; Tahereh Ghadiri; Zahra Payandeh; Vahideh Tarhriz
Journal:  Cancer Cell Int       Date:  2022-05-25       Impact factor: 6.429

2.  mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia.

Authors:  David T Teachey; Cecilia Sheen; Junior Hall; Theresa Ryan; Valerie I Brown; Jonathan Fish; Gregor S D Reid; Alix E Seif; Robin Norris; Yueh J Chang; Martin Carroll; Stephan A Grupp
Journal:  Blood       Date:  2008-06-10       Impact factor: 22.113

3.  Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma.

Authors:  Christopher M Mahaffey; Hongqiao Zhang; Alessandra Rinna; William Holland; Philip C Mack; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2009-04-05       Impact factor: 7.376

4.  Met promotes the formation of double minute chromosomes induced by Sei-1 in NIH-3T3 murine fibroblasts.

Authors:  Yantao Bao; Jia Liu; Jia You; Di Wu; Yang Yu; Chang Liu; Lei Wang; Fei Wang; Lu Xu; Liqun Wang; Nan Wang; Xing Tian; Falin Wang; Hongbin Liang; Yating Gao; Xiaobo Cui; Guohua Ji; Jing Bai; Jingcui Yu; Xiangning Meng; Yan Jin; Wenjing Sun; Xin-Yuan Guan; Chunyu Zhang; Songbin Fu
Journal:  Oncotarget       Date:  2016-08-30

Review 5.  Small ring has big potential: insights into extrachromosomal DNA in cancer.

Authors:  Yihao Wang; Rui Huang; Guopei Zheng; Jianfeng Shen
Journal:  Cancer Cell Int       Date:  2021-04-26       Impact factor: 5.722

6.  Oxidative stress and lipid peroxidation products in cancer progression and therapy.

Authors:  Giuseppina Barrera
Journal:  ISRN Oncol       Date:  2012-10-17

7.  Constitutive ERK1/2 activation contributes to production of double minute chromosomes in tumour cells.

Authors:  Wenjing Sun; Chao Quan; Yun Huang; Wei Ji; Lisa Yu; Xinxin Li; Yang Zhang; Zhibo Zheng; Hongyan Zou; Quanxiao Li; Ping Xu; Yan Feng; Li Li; Yunyan Zhang; Yunfu Cui; Xueyuan Jia; Xiangning Meng; Chunyu Zhang; Yan Jin; Jing Bai; Jingcui Yu; Yang Yu; Jianhua Yang; Songbin Fu
Journal:  J Pathol       Date:  2014-11-06       Impact factor: 7.996

Review 8.  Current understanding of extrachromosomal circular DNA in cancer pathogenesis and therapeutic resistance.

Authors:  Yuanliang Yan; Guijie Guo; Jinzhou Huang; Ming Gao; Qian Zhu; Shuangshuang Zeng; Zhicheng Gong; Zhijie Xu
Journal:  J Hematol Oncol       Date:  2020-09-14       Impact factor: 17.388

9.  Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance.

Authors:  Kana Oiwa; Naoko Hosono; Rie Nishi; Luigi Scotto; Owen A O'Connor; Takahiro Yamauchi
Journal:  BMC Cancer       Date:  2021-07-31       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.